首页> 外文学位 >Novel preparation of polymeric scaffolds for tissue engineering using phase separation with protein microbubble incorporation.
【24h】

Novel preparation of polymeric scaffolds for tissue engineering using phase separation with protein microbubble incorporation.

机译:用于组织工程的高分子支架的新型制备方法,是使用蛋白质微泡掺入的相分离技术。

获取原文
获取原文并翻译 | 示例

摘要

Poly (lactic-co-glycolic acid) (PLGA) has been extensively used as a biodegradable and porous tissue scaffold due to their biocompatibility and degradability. Several techniques have been developed for the fabrication of polymeric scaffolds but they all have some limitation or the other which has in turn hampered the growth of cells seeded on them. Salt leached scaffolds have good porosity and large pores but poor mechanical strength and the problem of residual salt even after leaching. Similarly gas foaming scaffolds have shown large pores but poor interconnection with residual ammonium salts. Other methods like thermally induced phase separation and fiber bonding do not involve the use of porogens and have yielded porous scaffolds although with small pores. To overcome these common problems, in this study, the use of protein microbubbles as a porogen and drug/protein carrier to produce polymeric scaffolds with good porosity was conceptualized. PLGA scaffolds were prepared by thermally induced phase separation with the incorporation of protein microbubbles. Two types of protein microbubbles, BSA and gelatin, were evaluated for their suitability as a porogen. The microbubbles which were incorporated in to the scaffolds at the time of fabrication were analyzed for their size and the scaffolds were characterized by SEM analysis and histological techniques. SEM revealed the synthesis of open pores measuring around 100 to 120 mum regardless of the type of protein used for synthesizing the microbubbles.;This novel technique provides two distinct advantages. First, microbubbles are made of biological materials which have no toxicity. Second, apart from having produced scaffolds with larger pores compared to conventional methods, our novel scaffold also has the potential to function as a delivery mechanism for chemokines and drugs in to the polymeric matrix. The scaffold can be degraded in a controlled manner to release the desired molecules to effect the desired cellular response.
机译:聚乳酸-乙醇酸共聚物(PLGA)由于其生物相容性和可降解性而被广泛用作可生物降解的多孔组织支架。已经开发了几种用于制造聚合物支架的技术,但是它们都具有一定的局限性,或者另一种阻碍了植入其上的细胞的生长。盐浸支架具有良好的孔隙率和大孔,但机械强度差,甚至浸出后仍存在残留盐的问题。同样,气体发泡支架也显示出大孔,但与残留铵盐的互连性差。其他方法,例如热诱导相分离和纤维粘合,不涉及使用致孔剂,尽管孔较小,但仍可产生多孔支架。为了克服这些常见问题,在这项研究中,将蛋白质微泡用作致孔剂和药物/蛋白质载体来生产具有良好孔隙率的聚合物支架的概念已得到概念化。通过热诱导相分离并结合蛋白质微泡来制备PLGA支架。评估了两种类型的蛋白质微气泡BSA和明胶作为致孔剂的适用性。分析在制造时掺入到支架中的微泡的大小,并通过SEM分析和组织学技术对支架进行表征。扫描电镜显示了大约100至120微米的开孔的合成,而与用于合成微泡的蛋白质的类型无关。首先,微泡是由无毒的生物材料制成的。其次,除了与常规方法相比,所生产的支架具有更大的孔外,我们的新型支架还具有作为趋化因子和药物向聚合物基质中输送的功能。支架可以受控方式降解以释放所需分子以实现所需细胞应答。

著录项

  • 作者

    Nair, Ashwin Mohan.;

  • 作者单位

    The University of Texas at Arlington.;

  • 授予单位 The University of Texas at Arlington.;
  • 学科 Biology Cell.;Engineering Biomedical.
  • 学位 M.S.
  • 年度 2004
  • 页码 72 p.
  • 总页数 72
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号